Renal cell carcinoma (advanced) - axitinib: appeal announcement
The Institute has received four appeals from Pfizer Ltd, James Whale Fund for Kidney Cancer, Kidney Cancer UK and Royal College of Physicians.
The Appeal hearing took place at Mercure Manchester Piccadilly, Portland Street, Manchester M1 4PH on Monday 10 June 2013 at 10.30am.
The Institute awaits the decision of the Appeal panel.
For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.
Below are the papers related to this appeal.
Renal cell carcinoma (advanced) - axitinib: Pfizer appeal documents
Renal cell carcinoma (advanced) - axitinib: James Whale Fund for Kidney Cancer appeal documents
Renal cell carcinoma (advanced) - axitinib: Kidney Cancer UK appeal documents
Renal cell carcinoma (advanced) - axitinib: Royal College of Physicians appeal documents
This page was last updated: 02 September 2013